Q2 FY2026 EarningsQ2 FY26 results beat consensus across key metrics, driven by robust 15.6% YoY revenue growth to $594.8M. Adjusted diluted EPS reached $0.59, exceeding the $0.548 consensus by 7.7%. The Healthcare and Life Sciences segment was a primary growth engine, with revenue up 22.0% YoY and significant gross margin expansion. Management raised FY26 revenue guidance to $2.39B–$2.415B, surpassing market expectations and reflecting strong visibility into AI-driven enterprise transformation demand.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: EXLService(EXLS) the Revenue is 594.76 M (+15.61%), Beat estimate;the EBIT is 87.3 M (+7.59%), Beat estimate;the EPS is 0.42 (+5%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.59B15.61%
0.57B11.56%
+0.02B4.05%
EBITExceed expectations
0.09B7.59%
0.09B6.64%
+0.00B0.95%
EPSMiss expectations
0.425.00%
0.4256.25%
-0.00501.25%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf